Does occasional cannabis use impact anxiety and depression treatment outcomes? Results from a randomized effectiveness trial

Depression and Anxiety

Volumn 24, Issue 6, 2007, Pages 392-398

  Bricker, Jonathan B ^a,b   Russo, Joan ^b   Stein, Murray B ^c   Sherbourne, Cathy ^d   Craske, Michelle ^e   Schraufnagel, Trevor J ^b   Roy Byrne, Peter ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d RAND CORPORATION   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anxiety; Cannabis; Depression; Primary care; Treatment

Indexed keywords

CANNABIS;

ADULT; ANXIETY DISORDER; ARTICLE; BEHAVIOR THERAPY; CANNABIS ADDICTION; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH CARE; OUTPATIENT CARE; PANIC; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SOCIAL PHOBIA; TREATMENT OUTCOME;

ADULT; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MARIJUANA SMOKING; MIDDLE AGED; PANIC DISORDER; PERSONALITY INVENTORY; PHOBIC DISORDERS; TREATMENT OUTCOME;

EID: 35348998364     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20248     Document Type: Article

References (32)

1. Agosti V, Nunes E, Levin F. 2002. Rates of psychiatric comorbidity among U.S. residents with lifetime cannabis dependence. Am J Drug Alcohol Abuse 28:643-652.
2. Barlow DH, Craske MG. 2000. Agoraphobia supplement. 3rd ed. Boulder, CO: Graywind.
3. Barlow DH, Gorman JM, Shear MK, Woods SW. 2000. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. JAMA 283:2529-2536.
4. Burnam MA, Morton SC, McGlynn EA, Petersen LP, Stecher BM, Hayes C, Vaccaco JV. 1995. An experimental evaluation of residential and nonresidential treatment for dually diagnosed homeless adults. J Addict Dis 14:111-134.
5. Chen CY, Wagner FA, Anthony JC. 2002. Marijuana use and the risk of major depressive episode: Epidemiological evidence from the United States National Comorbidity Survey. Soc Psychiatry Psychiatr Epidemiol 37:199-206.
6. Cornelius JR, Clark DB, Bukstein OG, Birmaher B, Salloum IM, Brown A. 2005. Acute phase and five-year follow-up study of fluoxetine in adolescents with major depression and a comorbid substance use disorder: A review. Addict Behav 30:1824-1833.
7. Craske MG, Barlow DH. 2000. Mastery of your anxiety and panic. 3rd ed. Boulder, CO: Graywind.
8. Craske MG, Roy-Byrne P, Stein MB, Donald-Sherbourne C, Bystritsky A, Katon W, Sullivan G. 2002. Treating panic disorder in primary care: A collaborative care intervention. Gen Hosp Psychiatry 24:148-155.
9. Dannon PN, Lowengrud K, Amiaz R, Grunhaus L, Kotler M. 2004. Comorbid cannabis use and panic disorder: Short term and long term follow-up study. Hum Psychopharmacol 19:97-101.
10. Farrell M. 1999. Cannabis dependence and withdrawal. Addiction 97: 1277-1278.
11. Hall W, Pacula RL. 2003. Cannabis use and dependence: Public Health and public policy. New York: Cambridge University Press.
12. Hann D, Winter K, Jacobsen P. 1999. Measurement of depressive symptoms in cancer patients: Evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res 46:437-443.
13. Hedeker D, Gibbons RD. 1996. MIXREG: A computer program for mixed-effects regression analysis with autocorrelated errors. Comput Methods Programs Biomed 49:229-252.
14. Katerndahl DA, Realini JP. 1999. Relationship between substance abuse and panic attacks. Addict Behav 24:731-736.
15. Lynskey MT, Glowinski AL, Todorov AA, Bucholz KK, Madden PA, Nelson EC, Statham DJ, Martin NG, Heath AC. 2004. Major depressive disorder, suicidal ideation, and suicide attempt in twins discordant for cannabis dependence and early-onset cannabis use. Arch Gen Psychiatry 61:1026-1032.
16. Marks IM, Matthews AM. 1979. Brief standard: Self-rating for phobic patients. Behav Res Ther 17:59-68.
17. Means-Christensen AJ, Sherbourne CD, Roy-Byrne PP, Shulman MC, Wu J, Dugdale DC, Lessler D, Stein MB. 2006. In search of mixed anxiety-depressive disorder: A primary care study. Depress Anxiety 23:183-189.
18. Radloff LS. 1977. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1: 385-401.
19. Rapee RM, Medoro L. 1994. Fear of physical sensations and trait anxiety as mediators of the response to hyperventilation in nonclinical subjects. J Abnorm Psychol 103:693-699.
20. Raphael B, Wooding S, Stevens G, Connor J. 2005. Comorbidity: Cannabis and complexity. J Psychiatr Pract 11:161-176.
21. Roy-Byrne PP, Craske MG, Stein MB, Sullivan G, Bystritsky A, Katon W, Golinelli D, Sherbourne CD. 2005. A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder. Arch Gen Psychiatry 62:290-298.
22. Roy-Byrne PP, Stang P, Wittchen HU, Ustun B, Walters EE, Kessler RC. 2000. Lifetime panic-depression comorbidity in the National Comorbidity Survey: Association with symptoms, impairment, course and help-seeking. Br J Psychiatry 176:229-235.
23. Roy-Byrne P, Stein M, Bystrisky A, Katon W. 1998. Pharmacotherapy of panic disorder: Proposed guidelines for the family physician. J Am Board Fam Pract 11:282-290.
24. Reiss S, Peterson RA, Gursky DM, McNally RJ. 1986. Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Ther 24:1-8.
25. Riggs PD, Mikulich SK, Coffman LM, Crowley TJ. 1997. Fluoxetine in drug-dependent delinquents with major depression: An open trial. J Child Adolesc Psychopharmacol 7:87-95.
26. Sbrana A, Bizarri JV, Rucci P, Gonnelli C, Doria MR, Spagnolli S, Ravani L, Raimondi F, Dell'Osso L, Cassano GB. 2005. The spectrum of substance use in mood and anxiety disorders. Compr Psychiatry 46:6-13.
27. Stein MB, Roy-Byrne PP, McQuaid JR, Laffaye C, Russo J, McCahill ME, Katon W, Craske M, Bystritsky A, Sherbourne CD. 1999. Development of a brief diagnostic screen for panic disorder in primary care. Psychosom Med 61:359-364.
28. Substance Abuse and Mental Health Services Administration. 1998. Results from the 1997 National Household Survey on Drug Abuse, Office of Applied Studies, DHHS Publication Number SMA 98-3251, Rockville, MD: Author.
29. Van Amerigen M, Oakman J, Mancini C, Pipe B, Chung H. 2004. Predictors of response in generalized social phobia: Effect of age of onset. J Clin Psychopharmacol 24:42-48.
30. Van Zuuren FJ. 1988. The fear questionnaire: Some data on validity, reliability and layout. Br J Psychiatry 153:659-662.
31. World Health Organization. 1997. Composite International Diagnostic Interview (CIDI) 2.1. Geneva, Switzerland: United Nations.
32. Zinbarg RE, Mohlman J, Hong NN. 1999. Dimensions of anxiety sensitivity. In: Taylor S, editor. Anxiety sensitivity: Theory, research, and treatment of the fear of anxiety. Mahwah, NJ: Erlbaum.